Radiopharmaceutical approved for relief of pain caused by bone metastases.
D001859:Bone Neoplasms / Q000556:secondary*; D017277:Drug Approval; D006801:Humans; D010146:Pain / Q000532:radiotherapy*; D010166:Palliative Care; D013324:Strontium / Q000008:administration & dosage / Q000627:therapeutic use*; D013326:Strontium Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D013326:Strontium Radioisotopes; C025700:strontium chloride; D013324:Strontium